ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RENX Renalytix Plc

13.50
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Renalytix Plc LSE:RENX London Ordinary Share GB00BYWL4Y04 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 13.50 13.00 14.00 13.50 13.50 13.50 66,213 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Services, Nec 3.4M -46.22M -0.2994 -0.45 20.84M
Renalytix Plc is listed in the Services sector of the London Stock Exchange with ticker RENX. The last closing price for Renalytix was 13.50p. Over the last year, Renalytix shares have traded in a share price range of 10.25p to 122.50p.

Renalytix currently has 154,368,191 shares in issue. The market capitalisation of Renalytix is £20.84 million. Renalytix has a price to earnings ratio (PE ratio) of -0.45.

Renalytix Share Discussion Threads

Showing 2801 to 2824 of 2825 messages
Chat Pages: 113  112  111  110  109  108  107  106  105  104  103  102  Older
DateSubjectAuthorDiscuss
16/7/2024
10:00
Wrong board mate.
jonjoalex
15/7/2024
14:37
Out on a profit today.
Who said trading was a bad thing. 👍

halland75
15/7/2024
08:03
Got in at 3.50.
Lucky me!

halland75
15/7/2024
07:33
Great company this.
But changing position here to GDR today.
Hopefully I can get in, in the 3's.

Will get back in here in the future.

halland75
14/7/2024
18:36
hxxps://youtu.be/MfRToHti858?si=5gCZbkoQERf5ZKeo
david56920
13/7/2024
15:20
Small Cap funds based on five-year performance.



The sales push
The long-term healthcare economics of KidneyIntelX is making it very popular with both public and private insurance providers. Renalytix has agreed a 10-year government-wide contract with the US General Services Administration for KidneyIntelX at $950 per test. This applies to more than 140 government agencies including a deal with the US Veterans Association (VA). The VA provides healthcare services to 9m veterans each year through 1,293 healthcare facilities. KidneyIntelX is also an accepted provider in 27 Medicaid State programs.

The private sector has taken a liking to the product as well. Coverage has been agreed with 20 private health insurance providers, including HealthFirst, one of New York State’s largest not-for-profit health insurance companies with more than 1.5m members.

Renalytix seemingly has a great product and the agreements with the insurance companies are very promising, but the business is still at a pre-commercial stage. In the full year to 30 June 2021, it generated just $1.5m in revenue. In the same period, administrative expenses and finance expenses were $33.3m and $7.95m, respectively, which contributed to losses for the period increasing to $31.0m from $9.25m.

david56920
12/7/2024
16:17
was America closed today ?
arab3
12/7/2024
09:49
Already showing a profit.
Looking forward to America joining the party later.

Good luck guys and enjoy your weekend, but above all Good Luck England. 🏆 🏆 🏆

halland75
12/7/2024
09:07
Just bought a little bit more.
halland75
12/7/2024
08:21
This move up has not finished.
Volume in the US was colossal yesterday, I don't think markets realise how big a deal the RNS is of yesterday.

Check Out the Novo Nordisk angle, they are the makers of Ozempic.
I think the rally continues today.

KidneyIntelX will be available for patients 1st August 2024.
I bought today. 👍

halland75
11/7/2024
22:03
$0.40 is circa 15-16p
thiopia
11/7/2024
13:25
UK lagging US price

US price RNLX at $0.60 is equivalent to around 23-24p here

US price RNLX at $0.50 is equivalent to around 19-20p here

thiopia
11/7/2024
12:25
this news from from Steno Copenhagen is significant
robow
25/6/2024
15:57
Looks like.i didnt miss much...
ivan danko
17/6/2024
12:48
The coverage determination enables Medicaid to pay for tests.

FDA approval, inclusion in treatment guidelines and now billable under Medicaid, the test and analysis is fully endorsed.

However not many clinicians have used the test yet……the credibility and expectation of use should drive take up.

US Clinicians are averse to taking on legal risk - and so will follow the guidelines.
The company probably needs to find an ambulance chasing lawyer to prosecute some cases where the test should have been used but was not.

1jat
16/6/2024
17:59
Why is last weeks news so important?
bertiebingo
16/6/2024
16:33
If you think you’re too late here try verici dx. Poised for greatness in a similar sector
collywobbler
14/6/2024
15:22
Ivan there still plenty of gains to be had here.
bri15
14/6/2024
14:55
Im too late to get in now..damn..
ivan danko
14/6/2024
14:46
US 20% up,that's just the start.
bri15
14/6/2024
14:44
F..k aye it is 😀
bri15
14/6/2024
14:17
Is this a promising company..i mean 14mil kits to US at 950 dollars...
ivan danko
14/6/2024
14:05
I be glued to Nasdaq on open,it's got to start high,and then keep rising, they will know the importance of today's RNS, unlike UK fools
bri15
14/6/2024
14:03
Yank market will rocket this.
bri15
Chat Pages: 113  112  111  110  109  108  107  106  105  104  103  102  Older

Your Recent History

Delayed Upgrade Clock